Three fears may discourage colorectal cancer screening

April 30, 2012 By Milly Dawson, Contributing Writer

New research about why people forego colorectal cancer (CRC) screening suggests that three fears play a significant role; fear of embarrassment, fear of getting AIDS and fear of pain may make some seniors skip the potentially lifesaving tests.

The strongest predictor of unwillingness to participate in screening was fear of embarrassment during a screening. Fear of getting AIDS, which prior studies have suggested revolve around the insertion of medical devices into the rectum, was the second strongest. Fear of pain was also associated with a reluctance to participate in screening.

“We found that people who feared that they might get AIDS, feared feeling embarrassed during the screening exam, those who were older, and those with only a high school education were more unwilling to get screened,” said lead author Shalanda Bynum, Ph.D., MPH, an assistant professor of social and behavioral sciences at the F. Edward Hebert School of Medicine at the Uniformed Services University of the Health Sciences.

While earlier research has shown that barriers to CRC screening include factors such as income and race/ethnicity, this study, in the American Journal of Health Promotion, sought to explore not only those factors but also psychosocial ones. It is one of the few studies to also address the influence of a person’s mistrust of medical providers and misconceptions, such as the notion that CRC screening might cause AIDS.

The AIDS issue warrants further investigation, said Jason Q. Purnell, Ph.D., MPH, an assistant professor at the George Warren Brown School of Social Work at Washington University. It also testifies to the need for public health efforts around CRC screening to increase patients’ knowledge and address their fears, said Bynum.

The findings were based on telephone survey data from 454 individuals 50 and older living in New York, Baltimore and San Juan. Study participants self-identified as African American, Hispanic or white. They were asked how willing they were to participate in colon screening and how much various fears or feelings, such as of finding out you have cancer or mistrust of doctors, would influence their decision.

One finding that the researchers and Purnell found surprising and consider worthy of closer study was that those who reported medical mistrust were less likely than others to indicate that they would not get screened for CRC.

Purnell said, “Medical mistrust may heighten a person’s sense of vigilance, making them more likely to undergo screenings in an attempt to guard against what they perceive as potentially inadequate care. The relationships of mistrust to colorectal may be more complex than we originally thought.”

People who generally feared developing cancers were also less likely to demonstrate avoidance of screening.

Although colorectal cancer rates have declined greatly in the past 20 years, it remains the second leading cause of cancer death in the US. Despite screening’s proven ability to prevent CRC, 38 percent of adults over 50 have never had a sigmoidoscopy/colonoscopy and 79 percent have never had a fecal occult blood test.

Explore further: Study examines adherence to colorectal cancer screening recommendations

Related Stories

Study examines adherence to colorectal cancer screening recommendations

April 9, 2012
Patients for whom colonoscopy was recommended were less likely to complete colorectal cancer screening than those patients for whom fecal occult blood testing (FOBT) was recommended or those patients who were given a choice ...

Single flexible sigmoidoscopy screening associated with reduced colorectal cancer

August 18, 2011
A single flexible sigmoidoscopy screening between the ages of 55-64 years is associated with a lower level of colorectal cancer (CRC) incidence and mortality, according to a study published online August 18 in the Journal ...

Fear, anxiety and embarrassment stop women going for breast screening

November 9, 2011
(Medical Xpress) -- Fear, anxiety and embarrassment are some of the main barriers preventing women from going for breast screening, but this alone does not account for the variations in uptake, according to new work presented ...

Recommended for you

Shooting the achilles heel of nervous system cancers

July 20, 2017
Virtually all cancer treatments used today also damage normal cells, causing the toxic side effects associated with cancer treatment. A cooperative research team led by researchers at Dartmouth's Norris Cotton Cancer Center ...

Molecular changes with age in normal breast tissue are linked to cancer-related changes

July 20, 2017
Several known factors are associated with a higher risk of breast cancer including increasing age, being overweight after menopause, alcohol intake, and family history. However, the underlying biologic mechanisms through ...

Immune-cell numbers predict response to combination immunotherapy in melanoma

July 20, 2017
Whether a melanoma patient will better respond to a single immunotherapy drug or two in combination depends on the abundance of certain white blood cells within their tumors, according to a new study conducted by UC San Francisco ...

Discovery could lead to better results for patients undergoing radiation

July 19, 2017
More than half of cancer patients undergo radiotherapy, in which high doses of radiation are aimed at diseased tissue to kill cancer cells. But due to a phenomenon known as radiation-induced bystander effect (RIBE), in which ...

Definitive genomic study reveals alterations driving most medulloblastoma brain tumors

July 19, 2017
The most comprehensive analysis yet of medulloblastoma has identified genomic changes responsible for more than 75 percent of the brain tumors, including two new suspected cancer genes that were found exclusively in the least ...

Novel CRISPR-Cas9 screening enables discovery of new targets to aid cancer immunotherapy

July 19, 2017
A novel screening method developed by a team at Dana-Farber/Boston Children's Cancer and Blood Disorders Center—using CRISPR-Cas9 genome editing technology to test the function of thousands of tumor genes in mice—has ...

0 comments

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.